Repeat laser interstitial thermal therapy for recurrent primary and metastatic intracranial tumors

BACKGROUND: Repeat craniotomy in patients with primary and metastatic brain tumors carries significant morbidity and can delay adjuvant treatments. Repeat laser interstitial thermal therapy (LITT) for recurrent disease has been described and could benefit patients with limited cytoreductive options. We aim to describe the indications, safety, and efficacy of repeat LITT for recurrent primary and metastatic intracranial tumors. METHODS: Patients undergoing repeat ablations for the same lesion were included in the study. We retrospectively analyzed 13 patients treated with 29 total LITT ablations. RESULTS: Eleven patients were treated for glioblastoma (GBM), while two had brain metastases. Eleven patients had LITT performed only 2 times, while three patients underwent three total iterations of LITT for disease recurrence. Median length of stay after the 1(st) ablation was 2 days, while the median length of stay after the 2(nd) ablation was 1 day. The median time to resuming adjuvant treatments after the 1(st) LITT was 11 days. The median time to resuming adjuvant treatments after the 2(nd) LITT was 28 days. Four patients after the 1(st) and 2(nd) LITT sustained deficits persisting through 30-day follow-up. The median progression-free survival among the GBM patients from the first ablation was 6.0 months, 3.2 months from the 2(nd) ablation, and 2.1 months from the 3(rd) ablation. CONCLUSION: Recurrent tumors, especially GBM, can be safely treated using repeat LITT when surgery cannot be effectively performed. Our results indicate that patients tolerate the procedure well and have a meaningful survival given the salvage nature of the procedure.